drugset / Trial / NCT00046969
Epoetin Beta in Treating Anemia in Patients With Cervical Cancer
RandomizedOpen-labelSupportive care
Summary
RATIONALE: Epoetin beta may stimulate red blood cell production to prevent or control anemia in patients treated with chemotherapy and radiation therapy. PURPOSE: Randomized phase IV trial to determine the effectiveness of epoetin beta in treating anemia in patients who are receiving cisplatin and radiation therapy for stage IIB, stage III, or stage IVA cervical cancer.
Timeline
- Start
- 2002-07
- Primary completion
- —
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | — | Subcutaneous |
| Background | Cisplatin | Other / unclassified | — | Intravenous |